Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment

Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment

Impaired sleep and low daily activity levels increase the risk of developing metabolic syndrome (MS). Metformin (MET), an insulin sensitizer drug, is effective in regressing MS and has been recently studied as an adjuvant agent for managing sleep disorders. The present study aimed to assess whether...

Full description

Bibliographic Details
Main Authors: Eleonora Bruno, Antonino Mulè, Letizia Galasso, Lucia Castelli, Ivan Baldassari, Andreina Oliverio, Elisabetta Venturelli, Franco Berrino, Angela Montaruli, Eliana Roveda, Patrizia Pasanisi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Nutrition
Subjects:
metformin
metabolic syndrome
lifestyle
sleep
rest-activity circadian rhythm
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1240762/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2023.1240762/full

Similar Items